Atulkumar Induprasad Patel

Title: Atulkumar Induprasad Patel: Innovator in Staphylococcus Aureus Antigens

Introduction

Atulkumar Induprasad Patel is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of medical diagnostics through his innovative work on Staphylococcus aureus antigens. With a total of 2 patents, Patel's inventions are aimed at improving the detection and treatment of infections caused by this bacterium.

Latest Patents

Patel's latest patents include a negatively-charged Staphylococcus aureus antigen that contains β-hexosamine as a major carbohydrate component. This antigen is crucial as strains that carry it account for nearly all clinically significant strains of Staphylococcus aureus that are not Type 5 or Type 8 strains. The antigen can be used in combination with Type 5 and Type 8 polysaccharide antigens to provide nearly 100% coverage of Staphylococcus aureus infections. Additionally, he has developed a Staphylococcus aureus B-linked hexosamine antigen, which also contains β-hexosamine and serves a similar purpose in infection coverage.

Career Highlights

Atulkumar Patel is currently employed at Nabi, where he continues to advance his research and development efforts. His work has been instrumental in creating diagnostic kits and assays that utilize the antigens he has developed, thereby enhancing the ability to diagnose Staphylococcus aureus infections effectively.

Collaborations

Patel collaborates with Ali Ibrahim Fattom, contributing to the innovative research environment at Nabi. Their combined expertise fosters advancements in the field of medical diagnostics.

Conclusion

Atulkumar Induprasad Patel's contributions to the field of Staphylococcus aureus antigens highlight his role as an important inventor in medical diagnostics. His patents not only advance scientific understanding but also improve clinical practices in infection detection and treatment.